Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$9.02 - $10.29 $2,146 - $2,449
238 Added 2.37%
10,278 $102,000
Q1 2023

Apr 21, 2023

SELL
$9.2 - $12.26 $2,355 - $3,138
-256 Reduced 2.49%
10,040 $96,000
Q4 2022

Feb 03, 2023

SELL
$8.72 - $11.56 $531 - $705
-61 Reduced 0.59%
10,296 $114,000
Q3 2022

Oct 19, 2022

BUY
$8.48 - $11.13 $87,827 - $115,273
10,357 New
10,357 $88,000
Q1 2022

May 06, 2022

SELL
$9.81 - $15.4 $78,862 - $123,800
-8,039 Closed
0 $0
Q4 2021

Feb 08, 2022

BUY
$12.09 - $14.68 $97,191 - $118,012
8,039 New
8,039 $108,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Retirement Planning CO Of New England, Inc. Portfolio

Follow Retirement Planning CO Of New England, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Retirement Planning CO Of New England, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Retirement Planning CO Of New England, Inc. with notifications on news.